Literature DB >> 22356187

The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2·7-fold increased risk of polycystic ovary syndrome in a Sardinian population.

A Capalbo1, F Sagnella, R Apa, A M Fulghesu, A Lanzone, A Morciano, A Farcomeni, M F Gangale, F Moro, D Martinez, A Ciardulli, C Palla, M L Uras, F Spettu, A Cappai, C Carcassi, G Neri, F D Tiziano.   

Abstract

OBJECTIVE: Polycystic ovary syndrome (PCOS) is a frequent condition, affecting about 15% of women of reproductive age. Because of its familial occurrence, a multifactorial model of susceptibility, including both genetic and environmental factors, has been proposed. However, the identification of genetic factors has been elusive.
DESIGN: Case-control study aimed at evaluating possible associations between functionally relevant variants of the luteinizing hormone/choriogonadotrophin receptor gene (LHCGR) and PCOS phenotype. PATIENTS: A total of 198 PCOS and 187 non-PCOS women, aged 14-35 years, of Sardinian origin, were referred to the outpatient clinic of the Department of Obstetrics and Gynaecology of the University of Cagliari (Sardinia). PCOS diagnosis was based on the Rotterdam criteria. MEASUREMENTS: We determined the genotype of ins18LQ, S291N and S312N variants at the LHCGR locus. Genotype was related to the presence or absence of PCOS and to several clinical and biochemical characteristics.
RESULTS: The presence of at least one 312N allele was strongly associated with PCOS risk (OR, 2·04; 95% CI, 1·32-3·14; χ(2) , 10·47; P = 0·001). 312N homozygosity was associated with a further risk increase (OR, 2·73; 95% CI, 1·25-5·95; χ(2) , 6·65; P = 0·01). The number of ins18LQ alleles was associated with LH serum levels in controls (χ(2) , 8·04, P = 0·017).
CONCLUSIONS: For the first time, we have identified a genetic variant that is strongly associated with PCOS in an isolated population. These results, if confirmed in other cohorts, may provide the opportunity to test the S312N genotype at the LHCGR locus in fertile women to assess the risk of PCOS. The avoidance of triggering factors like weight increase may improve the reproductive outcome of potentially at-risk subjects.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22356187     DOI: 10.1111/j.1365-2265.2012.04372.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  11 in total

1.  Association of luteinizing hormone chorionic gonadotropin receptor gene polymorphism (rs2293275) with polycystic ovarian syndrome.

Authors:  Sujatha Thathapudi; Vijayalakshmi Kodati; Jayashankar Erukkambattu; Uma Addepally; Hasan Qurratulain
Journal:  Genet Test Mol Biomarkers       Date:  2015-01-07

Review 2.  Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood.

Authors:  David H Abbott; Fida Bacha
Journal:  Fertil Steril       Date:  2013-07       Impact factor: 7.329

Review 3.  Functional genomics of PCOS: from GWAS to molecular mechanisms.

Authors:  Jan M McAllister; Richard S Legro; Bhavi P Modi; Jerome F Strauss
Journal:  Trends Endocrinol Metab       Date:  2015-01-15       Impact factor: 12.015

Review 4.  Effect of maternal PCOS and PCOS-like phenotype on the offspring's health.

Authors:  Muraly Puttabyatappa; Rodolfo C Cardoso; Vasantha Padmanabhan
Journal:  Mol Cell Endocrinol       Date:  2015-11-27       Impact factor: 4.102

Review 5.  Pathophysiological mechanisms of gonadotropins- and steroid hormones-related genes in etiology of polycystic ovary syndrome.

Authors:  Zahra Shaaban; Arezoo Khoradmehr; Mohammad Reza Jafarzadeh Shirazi; Amin Tamadon
Journal:  Iran J Basic Med Sci       Date:  2019-01       Impact factor: 2.699

Review 6.  Genetic, hormonal and metabolic aspects of PCOS: an update.

Authors:  V De Leo; M C Musacchio; V Cappelli; M G Massaro; G Morgante; F Petraglia
Journal:  Reprod Biol Endocrinol       Date:  2016-07-16       Impact factor: 5.211

7.  Identification of selected genetic polymorphisms in polycystic ovary syndrome in Sri Lankan women using low cost genotyping techniques.

Authors:  Umayal Branavan; Kajan Muneeswaran; Sulochana Wijesundera; Surangi Jayakody; Vishvanath Chandrasekharan; Chandrika Wijeyaratne
Journal:  PLoS One       Date:  2018-12-31       Impact factor: 3.240

8.  Evaluation of the Prevalence of Exons 1 And 10 Polymorphisms of LHCGR Gene and Its Relationship with IVF Success.

Authors:  Maliheh Javadi-Arjmand; Elia Damavandi; Hamid Choobineh; Fereshteh Sarafrazi-Esfandabadi; Majid Kabuli; Atoosa Mahdavi; Mohsen Ghadami
Journal:  J Reprod Infertil       Date:  2019 Oct-Dec

9.  Role of Single Nucleotide Variants in FSHR, GNRHR, ESR2 and LHCGR Genes in Adolescents with Polycystic Ovary Syndrome.

Authors:  Lasma Lidaka; Laine Bekere; Adele Rota; Jekaterina Isakova; Gunta Lazdane; Anda Kivite-Urtane; Iveta Dzivite-Krisane; Inga Kempa; Zane Dobele; Linda Gailite
Journal:  Diagnostics (Basel)       Date:  2021-12-11

10.  Effect of LHCGR Gene Polymorphism (rs2293275) on LH Supplementation Protocol Outcomes in Second IVF Cycles: A Retrospective Study.

Authors:  Ramaraju Ga; Ravikrishna Cheemakurthi; Madan Kalagara; Kavitha Prathigudupu; Kavitha Lakshmi Balabomma; Pranati Mahapatro; Sivanarayana Thota; Aruna Lakshmi Kommaraju; Sanni Prasada Rao Muvvala
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-11       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.